Latest News about VTRS
Recent news which mentions VTRS
   S&P 500 Losers: 22 Stocks With Negative Returns Over Past 10 Years, And This One's Getting The Boot
   
  
  
  August 26, 2025
  From Benzinga
 
   Greenlight Capital Announces Q2 2025 Trades: New Positions in FLR and VSCO, Exit From VTRS
   
  
  
  August 16, 2025
  From Benzinga
 From Benzinga
 
   Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum
   
  
  
  August 12, 2025
  From Benzinga
 
   Earnings Scheduled For August 7, 2025
   
  
  
  August 07, 2025
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks
   
  
  
  May 08, 2025
  From Benzinga
 From Benzinga
 
   Earnings Scheduled For May 8, 2025
   
  
  
  May 08, 2025
  From Benzinga
 
   Wall Street Mixed Ahead Of Fed Meeting, Alphabet Sinks: What's Driving Markets Wednesday?
   
  
  
  May 07, 2025
  From Benzinga
 
   Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
   
  
  
  May 06, 2025
  From Benzinga
 
   Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
   
  
  
  April 21, 2025
  From Benzinga
 From Motley Fool
 
   Viatris Agrees To $335 Million Opioid Settlement Framework
   
  
  
  April 07, 2025
  From Benzinga
 
   Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields
   
  
  
  April 04, 2025
  From Benzinga
 
   Tesla, Palantir And MicroStrategy Are Among Top 12 Large-Cap Losers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio?
   
  
  
  March 02, 2025
  From Benzinga
 From Benzinga
 
   Earnings Scheduled For February 27, 2025
   
  
  
  February 27, 2025
  From Benzinga
 
   CVS Health's Aetna Files Lawsuit Against Drugmakers For Alleged Inflated Generic Drug Prices
   
  
  
  January 06, 2025
  From Benzinga
 
   Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
   
  
  
  December 22, 2024
  From Benzinga
 
   Wall Street Closes At Record Highs After Reassurance From Powell: Magnificent 7 Hit $17 Trillion, Treasury Yields Erase Post-Election Spike
   
  
  
  November 07, 2024
  From Benzinga
 
   Generic Drugmaker Viatris Beats Expectations In Q3, CEO Praises $2 Billion Debt Paydown
   
  
  
  November 07, 2024
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
